2.96
price down icon6.33%   -0.20
after-market After Hours: 2.98 0.02 +0.68%
loading
Celularity Inc stock is traded at $2.96, with a volume of 138.00K. It is down -6.33% in the last 24 hours and up +57.45% over the past month. Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
See More
Previous Close:
$3.16
Open:
$3.14
24h Volume:
138.00K
Relative Volume:
0.61
Market Cap:
$70.89M
Revenue:
$48.20M
Net Income/Loss:
$-35.05M
P/E Ratio:
-1.8886
EPS:
-1.5673
Net Cash Flow:
$-13.02M
1W Performance:
-2.31%
1M Performance:
+57.45%
6M Performance:
+18.40%
1Y Performance:
-1.00%
1-Day Range:
Value
$2.95
$3.26
1-Week Range:
Value
$2.95
$4.35
52-Week Range:
Value
$1.06
$5.22

Celularity Inc Stock (CELU) Company Profile

Name
Name
Celularity Inc
Name
Phone
(908) 768-2170
Name
Address
170 PARK AVE, FLORHAM PARK
Name
Employee
123
Name
Twitter
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
CELU's Discussions on Twitter

Compare CELU with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CELU
Celularity Inc
2.96 75.68M 48.20M -35.05M -13.02M -1.5673
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Celularity Inc Stock (CELU) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-30-23 Downgrade Morgan Stanley Equal-Weight → Underweight
Dec-22-22 Downgrade Oppenheimer Outperform → Perform
Jun-22-22 Initiated H.C. Wainwright Buy
Apr-06-22 Downgrade Truist Buy → Hold
Jan-28-22 Initiated Oppenheimer Outperform
Nov-24-21 Initiated Morgan Stanley Equal-Weight
View All

Celularity Inc Stock (CELU) Latest News

pulisher
Jul 25, 2025

What analysts say about Celularity Inc. stockExponential wealth increase - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Celularity Inc. Equity Warrant stockFree Investment Community - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Celularity Inc. stock overhyped or has real potentialFree Investment Community - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Celularity Inc. stock priceMarket-beating performance - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Why Celularity Inc. Equity Warrant stock attracts strong analyst attentionFree AI-Driven Trading Strategies - Newser

Jul 25, 2025
pulisher
Jul 25, 2025

Celularity Inc. Stock Analysis and ForecastMassive profits - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Is Celularity Inc. Equity Warrant a good long term investmentPhenomenal capital gains - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Is Celularity Inc. a good long term investmentExponential wealth increase - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Celularity Inc. Equity Warrant stock priceBreakthrough profits - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Celularity Finalizes Private Placement Agreement - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Celularity Soared 23.8% Intraday, Could This Biotech Breakout Signal a New Bullish Era? - AInvest

Jul 22, 2025
pulisher
Jul 20, 2025

Celularity Inc. Equity Warrant Stock Analysis and ForecastOutstanding capital growth - Autocar Professional

Jul 20, 2025
pulisher
Jul 18, 2025

Will Celularity Inc. Equity Warrant stock benefit from AI tech trendsCarefully Curated High Return Stocks - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Celularity Stock Surges Over 8% Amid Florida Stem Cell Policy, New Partnership Boost - AInvest

Jul 17, 2025

Celularity Inc Stock (CELU) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):